United States · FDA National Drug Code directory

Levocetirizine Dihydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0093-7701_27746553-05ff-43dd-a541-26bb9a6e9a4c
Product NDC: 0093-7701
Form: TABLET, FILM COATED
Composition / generic term: Levocetirizine Dihydrochloride
Labeler: Teva Pharmaceuticals USA, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20110906
Source listing expiry: 20261231

Source-listed ingredients

LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

90 TABLET, FILM COATED in 1 BOTTLE (0093-7701-98) · 0093-7701-98

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →